Juan A. Páez, PhD (Staff Scientist)
E-mail address: email@example.com
Phone: +34 91 / +34 91 562 29 00
Fax: +34 91 564 48 53
Ph.D. in Organic Chemistry from the Complutense University of Madrid (1986). He joined the Medicinal Chemistry Institute in 1989, working in the design and synthesis of new drugs. His research interest is focused in the application of computational chemistry to drug design (neural network, theoretical calculation of molecular properties, QSAR, molecular modeling) in a broad range of therapeutic areas, cardiovascular (diuretics, antihypertensive, and antithrombotic agents), inflammatory diseases (bronchodilators) and in the CNS. During these years he has been involved in many drug discovery projects and has managed several projects in different therapeutic areas including SNC and neglected diseases. He has supervised four PhD theses and he is the author or co-author of more than sixty publications and ten patents. Currently, he is working in drug discovery against Chagas disease and the design and development of new cannabinoids for application in neurodegenerative disorders.
Concepción Pérez, PhD (Research Specialist)
E-mail address: firstname.lastname@example.org
Phone: +34 91 258 75 78/ +34 91 562 29 00
Fax: +34 91 564 48 53
Dr. Concepción Pérez Martín is Research Specialist at Medicinal Chemistry Institute of the Spanish National Council for Research (CSIC). She obtained her doctorate from «Universidad Complutense» of Madrid (Spain) in 1995, investigating the differentiation of U937 promonocytic cells by antitumor DNA topoisomerase II inhibitors. At the present time her interest is focused on «in vitro» and «in vivo» evaluation of new drug with potential activity against neurodegenerative disorder, such as GSK-3 inhibitors, PDE 7 inhibitors, and neurogenic drugs.
Nuria E. Campillo, PhD (Staff Scientist)
E-mail address: email@example.com
Office address: Centro de Investigaciones Biológicas. CSIC Ramiro de Maeztu 9, 28040 Madrid
Phone: +34 91 837 31 12 Ext.4336/4321
Fax: +34 91 536 04 32
Dr. Nuria Campillo received her Ph.D. from Autonoma of Madrid in 1997 under the supervision of Dr. J. Páez. After a postdoctoral appointment at Cambridge University (Prof. T. Blundell), she joined the Medicinal Chemistry Institute in 2001 (first, as Associate Researcher and since 2003 as Staff Scientist). Since april 2014, Dr. Campillo works in CIB. Her research interests is focused on the design, synthesis, and pharmacological evaluation of new compounds as potential drugs for neurodegenerative disorders and Chagas´disease. She is also interested in the use of artificial neural networks for the prediction of biological properties (activity, ADMET…).